These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Non-uniformity in the regional pattern of Lewy pathology in brains of dementia with Lewy bodies. Yamamoto R; Iseki E; Marui W; Togo T; Katsuse O; Kato M; Isojima D; Akatsu H; Kosaka K; Arai H Neuropathology; 2005 Sep; 25(3):188-94. PubMed ID: 16193834 [TBL] [Abstract][Full Text] [Related]
10. Formation and development of Lewy pathology: a critical update. Jellinger KA J Neurol; 2009 Aug; 256 Suppl 3():270-9. PubMed ID: 19711116 [TBL] [Abstract][Full Text] [Related]
11. Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson's disease and Dementia with Lewy bodies. Ferrer I; Blanco R; Carmona M; Puig B; Barrachina M; Gómez C; Ambrosio S J Neural Transm (Vienna); 2001; 108(12):1383-96. PubMed ID: 11810403 [TBL] [Abstract][Full Text] [Related]
12. Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe. Harding AJ; Broe GA; Halliday GM Brain; 2002 Feb; 125(Pt 2):391-403. PubMed ID: 11844739 [TBL] [Abstract][Full Text] [Related]
13. [Parkinson's disease, dementia with Lewy bodies, multiple system atrophy and alpha-synuclein]. Iwatsubo T Rinsho Shinkeigaku; 1999 Dec; 39(12):1285-6. PubMed ID: 10791099 [TBL] [Abstract][Full Text] [Related]
14. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study. Jellinger KA Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452 [TBL] [Abstract][Full Text] [Related]
15. Degeneration process of Lewy bodies in the brains of patients with dementia with Lewy bodies using alpha-synuclein-immunohistochemistry. Iseki E; Marui W; Akiyama H; Uéda K; Kosaka K Neurosci Lett; 2000 May; 286(1):69-73. PubMed ID: 10822155 [TBL] [Abstract][Full Text] [Related]
16. Early-onset dementia with Lewy bodies. Takao M; Ghetti B; Yoshida H; Piccardo P; Narain Y; Murrell JR; Vidal R; Glazier BS; Jakes R; Tsutsui M; Spillantini MG; Crowther RA; Goedert M; Koto A Brain Pathol; 2004 Apr; 14(2):137-47. PubMed ID: 15193026 [TBL] [Abstract][Full Text] [Related]
17. Cellular co-localization of phosphorylated tau- and NACP/alpha-synuclein-epitopes in lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies. Arima K; Hirai S; Sunohara N; Aoto K; Izumiyama Y; Uéda K; Ikeda K; Kawai M Brain Res; 1999 Oct; 843(1-2):53-61. PubMed ID: 10528110 [TBL] [Abstract][Full Text] [Related]
19. Age-associated prevalence and risk factors of Lewy body pathology in a general population: the Hisayama study. Wakisaka Y; Furuta A; Tanizaki Y; Kiyohara Y; Iida M; Iwaki T Acta Neuropathol; 2003 Oct; 106(4):374-82. PubMed ID: 12904992 [TBL] [Abstract][Full Text] [Related]
20. Colocalization of tau and alpha-synuclein epitopes in Lewy bodies. Ishizawa T; Mattila P; Davies P; Wang D; Dickson DW J Neuropathol Exp Neurol; 2003 Apr; 62(4):389-97. PubMed ID: 12722831 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]